Description of liver disease in a cohort of HIV/HBV coinfected patients
Pierre Sellier(Inserm), Carmelo Lafuente‐Lafuente(Assistance Publique – Hôpitaux de Paris), Guy G. Simoneau(Hôpital Fernand-Widal), Nathalie Schnepf(Assistance Publique – Hôpitaux de Paris), Inmaculada Jarrín(Instituto de Salud Carlos III), Marica Parrinello(Assistance Publique – Hôpitaux de Paris), Jennifer L. Evans(Ministère des Armées), M.-C. Mazeron(Assistance Publique – Hôpitaux de Paris)
Cited by 22
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Reappraisal of known malaria resistance loci in a large multicenter study
|Nature Genetics|2014|245
Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania
|Nature Communications|2019|223